Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Paralysis, Legs

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Paralysis, Legs in 4 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kastaneer, ME1
Maijers, MC1
Martina, JD1
Riva, N1
Morana, P1
Cerri, F1
Gerevini, S1
Amadio, S1
Formaglio, F1
Comi, G1
Comola, M1
Del Carro, U1
Hall, AP2
Lyburn, ID1
Spears, FD1
Riley, B1

Other Studies

4 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Paralysis, Legs

ArticleYear
Spinal cord injury after the use of ecstasy in a young male.
    Spinal cord series and cases, 2020, 04-28, Volume: 6, Issue:1

    Topics: Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paraplegia; Spinal Cord Injurie

2020
Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin.
    Journal of neurology, neurosurgery, and psychiatry, 2007, Volume: 78, Issue:8

    Topics: Acute Disease; Administration, Inhalation; Adolescent; Drug Overdose; Female; Hallucinogens; Heroin;

2007
An unusual case of Ecstasy poisoning.
    Intensive care medicine, 1996, Volume: 22, Issue:7

    Topics: Adult; Creatine Kinase; Dantrolene; Humans; Male; Muscle Relaxants, Central; N-Methyl-3,4-methylened

1996
Ecstasy: creatinine kinase.
    Anaesthesia and intensive care, 1997, Volume: 25, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Creatine Kinase; Dantrolene; Designer Drugs; Fever; Humans; Multiple

1997